Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The normal human prostate does not significantly affect blood DHT levels.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Alternative treatments show promise for hair growth beyond traditional methods.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

New treatments for PCOS focus on managing symptoms and improving fertility.

Testosterone helps human pancreatic cells increase insulin release.

Balding and low testosterone increase risk of urinary stones.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

PCOS-related infertility is managed with lifestyle changes and medications.

PCOS causes hormonal imbalance, leading to symptoms like irregular periods and infertility.

High testosterone increases heart disease risk in women with PCOS.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.